The molecular basis of clinical diversity in glycogenosis type II (Pompe's disease) was investigated by comparing the nature of acid alpha-glucosidase deficiency in cultured fibroblasts from 30 patients. Biosynthetic forms of acid alpha-glucosidase with different molecular mass were separated electrophoretically and identified by immunoblotting. Immuno-electron microscopy was employed to determine the intracellular localization of mutant enzyme. Our studies illustrate that maturation of acid alpha-glucosidase is associated with transport to the lysosomes. Deficiency of catalytically active mature enzyme in lysosomes is common to all clinical phenotypes but, in the majority of cases, is more profound in early onset than in late onset forms of the disease. Thus, the results suggest that the clinical course of glycogenosis type II is primarily determined by the amount of functional acid alpha-glucosidase. The role of secondary factors can, however, not be excluded because three adult patients were identified with very low activity and little enzyme in the lysosomes.
A J Reuser, M Kroos, R Willemsen, D Swallow, J M Tager, H Galjaard
Title and authors | Publication | Year |
---|---|---|
Broadening the Phenotype and Genotype Spectrum of Glycogen Storage Disease by Unraveling Novel Variants in an Iranian Patient Cohort.
Moghimi P, Hashemi-Gorji F, Jamshidi S, Tehrani Fateh S, Salehpour S, Sadeghi H, Norouzi Rostami F, Mirfakhraie R, Miryounesi M, Ghasemi MR |
Biochemical Genetics | 2024 |
Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy
AL McCall, SG Stankov, G Cowen, D Cloutier, Z Zhang, L Yang, N Clement, DJ Falk, BJ Byrne |
Current gene therapy | 2019 |
A molecular analysis of the GAA gene and clinical spectrum in 38 patients with Pompe disease in Japan
Y Fukuhara, N Fuji, N Yamazaki, A Hirakiyama, T Kamioka, JH Seo, R Mashima, M Kosuga, T Okuyama |
Molecular Genetics and Metabolism Reports | 2018 |
Novel probable pathological variant c.1249A>C in exon 7 of the GAA gene associated with Pompe disease in adults
JC Bueno, CA Sánchez, FS de Sotomayor, S Izquierdo-Álvarez, MD Gallart, JS García |
Neurología (English Edition) | 2018 |
Skeletal alterations, developmental delay and new mutations in juvenile-onset Pompe disease
J Guevara-Campos, L González-Guevara, O Cauli |
Neuromuscular Disorders | 2018 |
Nueva variante probablemente patogénica c.1249A>C en el exón 7 del gen GAA asociada a la enfermedad de Pompe del adulto
JC Bueno, CA Sánchez, FS de Sotomayor, S Izquierdo-Álvarez, MD Gallart, JS García |
Neurologia (Barcelona, Spain) | 2017 |
Valores de referencia de la actividad enzimática alfa-glucosidasa ácida linfocitaria
BC Figueruelo, PD Parejo, JB Lobato, LM Jiménez |
Revista del Laboratorio Clínico | 2016 |
Neuromuscular Disorders in Clinical Practice
B Katirji, HJ Kaminski, RL Ruff |
2013 | |
The genotype-phenotype correlation in Pompe disease
M Kroos, M Hoogeveen-Westerveld, A der Ploeg, AJ Reuser |
American Journal of Medical Genetics Part C Seminars in Medical Genetics | 2012 |
Swaiman's Pediatric Neurology
GM Enns, TM Cowan, O Klein, S Packman |
Swaiman's Pediatric Neurology | 2012 |
A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations
A Herzog, R Hartung, AJ Reuser, P Hermanns, H Runz, N Karabul, S Gökce, J Pohlenz, C Kampmann, C Lampe, M Beck, E Mengel |
Orphanet Journal of Rare Diseases | 2012 |
Discovery of a novel non-iminosugar acid alpha glucosidase chaperone series
J Xiao, W Westbroek, O Motabar, WA Lea, X Hu, A Velayati, W Zheng, N Southall, AM Gustafson, E Goldin, E Sidransky, K Liu, A Simeonov, RJ Tamargo, A Ribes, L Matalonga, M Ferrer, JJ Marugan |
Journal of Medicinal Chemistry | 2012 |
Discovery, SAR, and Biological evaluation of Non-Inhibitory Small Molecule Chaperones of Glucocerebrosidase
S Patnaik, W Zheng, JH Choi, O Motabar, N Southall, W Westbroek, WA Lea, A Velayati, E Goldin, E Sidransky, W Leister, JJ Marugan |
Journal of Medicinal Chemistry | 2012 |
JIMD Reports - Case and Research Reports, 2012/4
G Brown, E Morava, V Peters, KM Gibson, J Zschocke |
JIMD Reports - Case and Research Reports, 2012/4 | 2012 |
Metabolic disorders of fetal life: Glycogenoses and mitochondrial defects of the mitochondrial respiratory chain
S DiMauro, C Garone |
Seminars in Fetal and Neonatal Medicine | 2011 |
Molecular analysis and protein processing in late-onset pompe disease patients with low levels of acid α-glucosidase activity
DS Bali, AA Tolun, JL Goldstein, J Dai, PS Kishnani |
Muscle & Nerve | 2011 |
Novel Mutations in the Gene Encoding Acid α-1,4-glucosidase in a Patient with Late-onset Glycogen Storage Disease Type II (Pompe Disease) with Impaired Intelligence
T Muraoka, K Murao, H Imachi, F Kikuchi, T Yoshimoto, H Iwama, H Hosokawa, I Nishino, T Fukuda, H Sugie, K Adachi, E Nanba, T Ishida |
Internal Medicine | 2011 |
Evaluation of 2-thioxo-2,3,5,6,7,8-hexahydropyrimido[4,5-d]pyrimidin-4(1H)-one analogues as GAA activators
JJ Marugan, W Zheng, O Motabar, N Southall, E Goldin, E Sidransky, RA Aungst, K Liu, SK Sadhukhan, CP Austin |
European Journal of Medicinal Chemistry | 2010 |
A new resorufin-based alpha-glucosidase assay for high-throughput screening
O Motabar, ZD Shi, E Goldin, K Liu, N Southall, E Sidransky, CP Austin, GL Griffiths, W Zheng |
Analytical Biochemistry | 2009 |
Enzymatic and molecular strategies to diagnose Pompe disease
AJ Reuser, FW Verheijen, MA Kroos, T Okumiya, OP Diggelen, AT der Ploeg, DJ Halley |
Expert Opinion on Medical Diagnostics | 2009 |
Progress in enzyme replacement therapy in glycogen storage disease type II
C Angelini, C Semplicini, P Tonin, M Filosto, E Pegoraro, G Sorarù, M Fanin |
Therapeutic advances in neurological disorders | 2009 |
Nutritional Therapy for Glycogen Storage Diseases
S Heller, L Worona, A Consuelo |
Journal of Pediatric Gastroenterology and Nutrition | 2008 |
Pompe's disease
AT van der Ploeg, AJ Reuser |
The Lancet | 2008 |
Chemical chaperones improve transport and enhance stability of mutant α-glucosidases in glycogen storage disease type II
T Okumiya, MA Kroos, LV Vliet, H Takeuchi, AT van der Ploeg, AJ Reuser |
Molecular Genetics and Metabolism | 2007 |
Structural and biochemical studies on Pompe disease and a "pseudodeficiency of acid alpha-glucosidase"
Y Tajima, F Matsuzawa, S Aikawa, T Okumiya, M Yoshimizu, T Tsukimura, M Ikekita, S Tsujino, A Tsuji, T Edmunds, H Sakuraba |
Journal of Human Genetics | 2007 |
Glycogen storage diseases: new perspectives
H Ozen |
World journal of gastroenterology : WJG | 2007 |
Lysosomal Storage Disorders
JA Barranger, MA Cabrera-Salazar |
2007 | |
Correlation of acid α-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease
K Umapathysivam, JJ Hopwood, PJ Meikle |
Clinica Chimica Acta | 2005 |
Pregnancy in a healthy woman with untreated citrullinemia
MA Potter, S Zeesman, B Brennan, K Kobayashi, HZ Gao, A Tabata, T Saheki, DT Whelan |
American Journal of Medical Genetics | 2004 |
Twenty-two novel mutations in the lysosomal ?-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type II
MM Hermans, D Leenen, MA Kroos, CE Beesley, AT van der Ploeg, H Sakuraba, R Wevers, W Kleijer, H Michelakakis, EP Kirk, J Fletcher, N Bosshard, L Basel-Vanagaite, G Besley, AJ Reuser |
Human Mutation | 2003 |
Identification of six novel mutations in the acid alpha-glucosidase gene in three Spanish patients with infantile onset glycogen storage disease type II (Pompe disease)
R Fernandez-Hojas, ML Huie, C Navarro, C Dominguez, M Roig, D Lopez-Coronas, S Teijeira, K Anyane-Yeboa, R Hirschhorn |
Neuromuscular Disorders | 2002 |
THE MOLECULAR DIAGNOSIS OF METABOLIC MYOPATHIES
GD Vladutiu |
Neurologic Clinics | 2000 |
Neonatal metabolic myopathies
I Tein |
Seminars in Perinatology | 1999 |
Decreased activity of acid α-glucosidase in a patient with persistent periocular swelling after infusions of hydroxyethyl starch
Kiehl, Metze, Kresse, Reimann, Kraft, Kapp |
British Journal of Dermatology | 1998 |
Glycogen storage disease type II: Genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry
MM Hermans, MA Kroos, JA Smeitink, AT van der Ploeg, WJ Kleijer, AJ Reuser |
Human Mutation | 1998 |
Frequent mutation in Chinese patients with infantile type of GSD II in Taiwan: Evidence for a founder effect
JJ Shieh, CY Lin |
Human Mutation | 1998 |
Glycogen-Storage Disease Type II (Acid Maltase Deficiency): Identification of a Novel Small Deletion (delCC482+483) in French Patients
M Nicolino, JP Puech, F Letourneur, M Fardeau, A Kahn, L Poenaru |
Biochemical and Biophysical Research Communications | 1997 |
A mutation in a highly conserved region in brush-border sucrase-isomaltase and lysosomal alpha-glucosidase results in Golgi retention
CE Moolenaar, J Ouwendijk, M Wittpoth, HA Wisselaar, HP Hauri, LA Ginsel, HY Naim, JA Fransen |
Journal of cell science | 1997 |
Genetic defects in patients with glycogenosis type II (acid maltase deficiency)
N Raben, RC Nichols, C Boerkoel, P Plotz |
Muscle & Nerve | 1995 |
Glycogenosis type II (acid maltase deficiency)
AJ Reuser, MA Kroos, MM Hermans, AG Bijvoet, MP Verbeet, OP van Diggelen, WJ Kleijer, AT van der Ploeg |
Muscle & Nerve | 1995 |
Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II
CF Boerkoel, R Exelbert, C Nicastri, RC Nichols, FW Miller, PH Plotz, N Raben |
The American Journal of Human Genetics | 1995 |
Lysosomal storage diseases
V Gieselmann |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 1995 |
An evaluation of the potential side-effects of α-glucosidase inhibitors used for the management of diabetes mellitus
AJ Reuser, HA Wisselaar |
European Journal of Clinical Investigation | 1994 |
Two mutations affecting the transport and maturation of lysosomal α-glucosidase in an adult case of glycogen storage disease type II
MM Hermans, MA Kroos, ED Graaff, BA Oostra, AJ Reuser |
Human Mutation | 1993 |
Synthesis and In Situ Localization of Lysosomal α-Glucosidase in Muscle of an Unusual Variant of Glycogen Storage Disease Type II
R Willemsen, AT van der Ploeg, HF Busch, PE Zondervan, CJ van Noorden, AJ Reuser |
Ultrastructural Pathology | 1993 |
The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II
MM Hermans, E Graaff, MA Kroos, HA Wisselaar, R Willemsen, BA Oostra, AJ Reuser |
Biochemical Journal | 1993 |
Human lysosomal alpha-glucosidase: functional characterization of the glycosylation sites
MM Hermans, HA Wisselaar, MA Kroos, BA Oostra, AJ Reuser |
Biochemical Journal | 1993 |
Preparation of Monoclonal Antibodies Against Acid α-D-Glucosidase for Study of Chinese Glycogenosis Type II Patients
CY Lin, SY Lee, ZN Chang, SN Su, B Hwang, SH Han |
Hybridoma | 1992 |
Recombinant Human Acid α-Glucosidase Generated in Bacteria: Antigenic, but Enzymatically Inactive
F Martiniuk, S Tzall, A Chen |
DNA and Cell Biology | 1992 |
Lysosomal β-hexosaminidase is highly resistant towards proteolytic degradation in vitro
B Overdijk, EP Beem, CJ der Wal, CA Jongenelen |
International Journal of Biochemistry | 1992 |
?Reducing body?-like inclusions in skeletal muscle in childhood-onset acid maltase deficiency
V Jay, J Christodoulou, A Mercer-Connolly, RR McInnes |
Acta Neuropathologica | 1992 |
Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice
AT van der Ploeg, MA Kroos, R Willemsen, NH Brons, AJ Reuser |
Journal of Clinical Investigation | 1991 |
Identification of a Missense Mutation in an Adult-Onset Patient with Glycogenosis Type II Expressing Only One Allele
F Martiniuk, M Mehler, M Bodkin, S Tzall, K Hirschhorn, N Zhong, R Hirschhorn |
DNA and Cell Biology | 1991 |
Acid maltase deficiency presenting with a myopathy and exercise induced urinary incontinence in a 68 year old male
AM Chancellor, CP Warlow, JN Webb, MG Lucas, GT Besley, DM Broadhead |
Journal of neurology, neurosurgery, and psychiatry | 1991 |
Identification of the promoter region and gene expression for human acid alpha glucosidase
S Tzall, F Martiniuk |
Biochemical and Biophysical Research Communications | 1991 |
Identification of a point mutation in the human lysosomal α-glucosidase gene causing infantile glycogenosis type II
MM Hermans, E Graaff, MA Kroos, HA Wisselaar, BA Oostra, AJ Reuser |
Biochemical and Biophysical Research Communications | 1991 |
Biosynthesis of human α-N-acetylgalactosaminidase: Defective phosphorylation and maturation in infantile α-NAGA deficiency
P Hu, AJ Reuser, HC Janse, WJ Kleijer, D Schindler, H Sakuraba, A Tsuji, Y Suzuki, OP Diggelen |
Biochemical and Biophysical Research Communications | 1991 |
Quantitative relationship of lysosomal glycogen accumulation to lysosomal α-glucosidase inhibition in castanospermine-treated rats
BL Rhinehart, ME Begovic, KM Robinson |
Biochemical Pharmacology | 1991 |
Antenatal Diagnosis of Fetal Abnormalities
JO Drife, D Donnai |
1991 | |
Muscle glycogenosis
SW Moses |
Journal of Inherited Metabolic Disease | 1990 |
Sequence of the cDNA and 5′-Flanking Region for Human Acid α-Glucosidase, Detection of an Intron in the 5′ Untranslated Leader Sequence, Definition of 18-bp Polymorphisms, and Differences with Previous cDNA and Amino Acid Sequences
F Martiniuk, M Mehler, S Tzall, G Meredith, R Hirschhorn |
DNA and Cell Biology | 1990 |
Identification of the base-pair substitution responsible for a human acid alpha glucosidase allele with lower "affinity" for glycogen (GAA 2) and transient gene expression in deficient cells
F Martiniuk, M Bodkin, S Tzall, R Hirschhorn |
The American Journal of Human Genetics | 1990 |
Extensive genetic heterogeneity in patients with acid alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA
F Martiniuk, M Mehler, S Tzall, G Meredith, R Hirschhorn |
The American Journal of Human Genetics | 1990 |
Adult and infantile glycogenosis type II in one family, explained by allelic diversity
LH Hoefsloot, AT van der Ploeg, MA Kroos, M Hoogeveen-Westerveld, BA Oostra, AJ Reuser |
The American Journal of Human Genetics | 1990 |
Characterization of the human lysosomal alpha-glucosidase gene
LH Hoefsloot, M Hoogeveen-Westerveld, AJ Reuser, BA Oostra |
Biochemical Journal | 1990 |
Expression and routeing of human lysosomal alpha-glucosidase in transiently transfected mammalian cells
LH Hoefsloot, R Willemsen, MA Kroos, M Hoogeveen-Westerveld, MM Hermans, AT van der Ploeg, BA Oostra, AJ Reuser |
Biochemical Journal | 1990 |
Diagnosis of glycogen storage disease
YS Shin |
Journal of Inherited Metabolic Disease | 1990 |
9 The genetics of metabolic disorders of muscle
J Poulton, J Land |
Baillière's Clinical Endocrinology and Metabolism | 1990 |
5 Normal metabolism and disorders of carbohydrate metabolism
T Barsy, HG Hers |
Baillière's Clinical Endocrinology and Metabolism | 1990 |
Carbohydrate and Glycoprotein Metabolism; Maternal Phenylketonuria
RA Harkness, RJ Pollitt, GM Addison |
1990 | |
Glycogenosis type II: protein and DNA analysis in five South African families from various ethnic origins
AT van der Ploeg, LH Hoefsloot, M Hoogeveen-Westerveld, EM Petersen, AJ Reuser |
The American Journal of Human Genetics | 1989 |
An investigation of the possible influence of neutral ?-glucosidases on the clinical heterogeneity of glycogenosis type II
AT van der PLOEG, MA Kroos, DM Swallow, AJ Reuser |
Annals of Human Genetics | 1989 |
Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid α-glucosidases in human fibroblasts and HepG2 cells
HA Wisselaar, JM Dongen, AJ Reuser |
Clinica Chimica Acta | 1989 |
Mature 98,000-dalton acid ?-glucosidase is deficient in Japanese quails with acid maltase deficiency
Y Suhara, S Ishiura, T Tsukahara, H Sugita |
Muscle & Nerve | 1989 |
An investigation of the properties and possible clinical significance of the lysosomal ?-glucosidase GAA 2 allele
DM Swallow, M Kroos, AT van der PLOEG, B Griffiths, I Islam, CB Marenah, AJ Reuser |
Annals of Human Genetics | 1989 |
Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex
LH Hoefsloot, M Hoogeveen-Westerveld, MA Kroos, J Beeumen, AJ Reuser, BA Oostra |
The EMBO Journal | 1988 |
Alterations of the posttranslational processing of a lysosomal enzyme in C6 glioma cells
DS Snyder, JN Whitaker |
Journal of Neuroscience Research | 1988 |
Km mutant of acid α-glucosidase in a case of cardiomyopathy without signs of skeletal muscle involvement
Y Suzuki, A Tsuji, K Omura, G Nakamura, S Awa, M Kroos, AJ Reuser |
Clinical Genetics | 1988 |
Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells
AT Ploeg, PA Bolhuis, RA Wolterman, JW Visser, MC Loonen, HF Busch, AJ Reuser |
Journal of Neurology | 1988 |
Lipid Storage Disorders
R Salvayre, L Douste-Blazy, S Gatt |
1988 | |
Breakdown of lysosomal glycogen in cultured fibroblasts from glycogenosis type II patients after uptake of acid α-glucosidase
AT van der Ploeg, M Kroos, JM van Dongen, WJ Visser, PA Bolhuis, MC Loonen, AJ Reuser |
Journal of the Neurological Sciences | 1987 |
Cell-free translation of human lysosomal α-glucosidase: Evidence for reduced precursor synthesis in an adult patient with glycogenosis type II
GT van der Horst, EH Hoefsloot, MA Kroos, AJ Reuser |
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | 1987 |
Metabolic myopathies
S DiMauro, AF Miranda, S Sakoda, EA Schon, S Servidei, S Shanske, M Zeviani, JM Opitz, JF Reynolds |
American Journal of Medical Genetics | 1986 |
Clinical Chemistry
RM Archibald |
Analytical Chemistry | 1953 |